|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.95 EUR | +3.12% |
|
+7.11% | -5.71% |
| Apr. 29 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
| Apr. 26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
Stratec SE reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 261.91 million compared to EUR 274.63 million a year ago. Net income was EUR 13.07 million compared to EUR 29.22 million a year ago.
Basic earnings per share from continuing operations was EUR 1.07 compared to EUR 2.41 a year ago. Diluted earnings per share from continuing operations was EUR 1.07 compared to EUR 2.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.71% | 541M | |
| +8.69% | 219B | |
| +6.69% | 183B | |
| +10.90% | 133B | |
| +25.41% | 108B | |
| +0.27% | 63.06B | |
| +12.72% | 52.02B | |
| +3.96% | 48.2B | |
| +0.40% | 40.37B | |
| +15.03% | 39.35B |
STRATEC SE 
